Sclerotherapy continues to be the treatment of choice for varicose veins in the legs. However, isolated treatment using microfoam or lasers requires a high number of sessions to eliminate them. In 2013, we published results about the efficacy and safety 3 years after the combined treatment with microfoam injections and subsequent application of Nd:YAG laser. The aim of this paper is to clinically evaluate the treatment of varices in a control visit after 5 years, when polidocanol microfoam is used and is immediately irradiated in the tissue with 1064-nm Nd:YAG laser beam. The outcome persistence after 5 years was studied in the legs that had received combined treatment and had been studied 3 years after treatment. Patients were contacted by phone, interviewed, and examined with echo-Doppler. Out of the 259 patients who were contacted, 221 agreed to make the appointment, although in the end, only 202 came, which meant analysing 404 legs. At 5 years, the clearance rates were very high: patients were included in class CEAP C1 showing vessels of from 0.5 to 3 mm diameter. The patients showed a high level of satisfaction. Regarding adverse effects, only 4 cases of hypopigmentation described in the previous publication persisted. Although the action mechanisms between the microfoam and the Nd:YAG laser must still be elucidated, it is notable that combining microfoam with laser exposure obtained a complete, effective treatment of legs in only 2 sessions, with high clearance rates and high level of satisfaction among patients.
This is a preview of subscription content, log in to check access.
The authors Mihail L. Pascu and Adriana Smarandache were supported by MCI through the Nucleu Programme (ctr. no. 1813/2018) and CNCS/CCCDI - UEFISCDI project PN-III-P2-2.1-PED-2016-0420.
Compliance with ethical standards
The interview and study methodology were approved by the Ethics Committee of the Fundación Antoni de Gimbernat, and all patients who agreed to participate at control visit for evaluation of the results signed an informed consent form.
Conflict of interest
The authors declare that they have no conflict of interest.
Rabe E, Schliephake D, Otto J et al (2010) Sclerotherapy of telangiectases and reticular veins: a double-blind randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology 25(3):124–131CrossRefPubMedGoogle Scholar
Alós J, Carreño P, López JA et al (2006) Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc 31(1):101–107CrossRefGoogle Scholar
Sadick NS, Prieto VG, Shea CR et al (2001) Clinical and pathophysiologic correlates of 1064-nm Nd:YAG laser treatment of reticular veins and venulectasias. Arch Dermatol 137(5):613–617PubMedGoogle Scholar
Sadick NS (2001) Long-term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg 27(4):365–369PubMedGoogle Scholar
Moreno-Moraga J, Smarandache A, Pascu ML et al (2014) 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Phlebology 29(10):658–666CrossRefPubMedGoogle Scholar
Smarandache A, Trelles M, Pascu ML (2010) Measurement of the modifications of polidocanol absorption spectra after exposure to NIR laser radiation. J Optoelectron Adv Mater 12(9):1942–1945Google Scholar
Smarandache A (2012) Laser beams interaction with polidocanol foam: molecular background. Photomed Laser Surg 30(59):262–267CrossRefPubMedGoogle Scholar
Moreno-Moraga J, Hernández E, Royo J et al (2013) Optimal and safe treatment of spider leg veins measuring less than 1.5 mm on skin type IV patients, using repeated low-fluence Nd:YAG laser pulses after polidocanol injection. Lasers Med Sci 28(3):925–933CrossRefPubMedGoogle Scholar
Ross EV, Domankevitz Y (2005) Laser treatment of leg veins: physical mechanisms and theoretical considerations. Lasers Surg Med 36(2):105–116CrossRefPubMedGoogle Scholar
Tessari L (2001) Extemporary sclerosing foam according to personal method: experimental clinical data and catheter usage. Int Angiol 20(Suppl 1):54Google Scholar
Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27(1):58–60Google Scholar
Cavezzi A, Frullini A, Ricci S et al (2002) Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 17(1):13–18CrossRefGoogle Scholar
Trelles MA, Allones I, Alvarez J et al (2006) The 800-nm diode laser in the treatment of leg veins: assessment at 6 months. J Am Acad Dermatol 54(2):282–289CrossRefPubMedGoogle Scholar
Sadick N (2003) Laser treatment with a 1064-nm laser for lower extremity class I-III veins employing variable spots and pulse width parameters. Dermatol Surg 29(9):916–919PubMedGoogle Scholar
Mordon S, Brisot D, Fournier N (2003) Using a “non-uniform pulse sequence” can improve selective coagulation with a Nd:YAG laser (1.06 microm) thanks to met-hemoglobin absorption: a clinical study on blue leg veins. Lasers Surg Med 32(2):160–170CrossRefPubMedGoogle Scholar
Levy J, Elbahr C, Jouve E, Mordon S (2004) Comparison and sequential study of long pulsed Nd:YAG 1064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med 34(3):273–276CrossRefPubMedGoogle Scholar
Heger M, Beek JF, Moldovan NI et al (2005) Towards optimization of selective photothermolysis: prothrombotic pharmaceutical agents as potential adjuvants in laser treatment of port wine stains: a theoretical study. Thromb Haemost 93(2):242–256CrossRefPubMedGoogle Scholar
Conrad P, Malouf GM, Stacey MC (1995) The Australian polidocanol (aethoxyskclerol) study. Results at 2 years. Dermatol Surg 21(4):334–336 discussion 337-8CrossRefPubMedGoogle Scholar
Parlar B, Blazek C, Cazzaniga S et al (2015) Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol 29(3):549–554CrossRefPubMedGoogle Scholar
Altshuler GB, Anderson RR, Manstein D, Zenzie HH, Smirnov MZ (2001) Extended theory of selective photothermolysis. Lasers Surg Med 29(5):416–432CrossRefPubMedGoogle Scholar
Bäumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G (2006) Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Brit J Dermatol 155(2):364–371CrossRefGoogle Scholar
Parlette EC, Groff WF, Kinshella MJ et al (2006) Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser. Lasers Surg Med 38(2):98–105CrossRefPubMedGoogle Scholar
Murphy MJ, Torstensson PA (2014) Thermal relaxation times: an outdated concept in photothermal treatments. Lasers Surg Med 29(3):973–978CrossRefGoogle Scholar
Sommer AP, Zhu D, Mester AR, Försterling H-D (2011) Pulsed laser light forces cancer cells to absorb anticancer drugs--the role of water in nanomedicine. Artif Cells Blood Substit Immobil Biotechnol 39:169–173CrossRefPubMedGoogle Scholar
Sommer AP, Caron A, Fecht HJ (2008) Tuning nanoscopic water layers on hydrophobic and hydrophilic surfaces with laser light. Langmuir 24(3):635–636CrossRefPubMedGoogle Scholar
Sommer AP, Bieschke J, Friedrich RP, Zhu D, Wanker EE, Fecht HJ, Mereles D, Hunstein W (2012) 670 nm laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer’s disease? Photomed. Laser Surg 30:54–60CrossRefGoogle Scholar
Nastasa V, Boni M, Stoicu A, Dinache A, Smarandache A, Pascu ML (2016) Lasers in foams and emulsions studies. In: Pascu ML (ed) Laser optofluidics in fighting multiple drug resistance. Bentham Science Publishers, Sharjah, pp 303–350Google Scholar
Smarandache A, Staicu A, Nastasa V, Moreno-Moraga J, Royo de la Torre J, Trelles M, Pirvulescu R, Pascu ML (2015) Physical properties of laser irradiated sclerosing foams. Rom Rep Phys 67(4):1480–1490Google Scholar